Skip to main content
. 2011 Feb 9;2(1):50–62. doi: 10.4338/ACI-2010-04-RA-0026

Table 2.

Medication classes identified by the expert panel for generating therapeutic duplication alerts. If a patient has two drugs in any single class an alert is generated. Alerts are also generated if drugs from each of the medication class pairs are concurrently prescribed

  • 1.

    Angiotension-converting enzyme (ACE) Inhibitors

  • 2.

    Angiotensin 2 Receptor Blockers (ARB)

  • 3.

    Benzodiazepines

  • 4.

    Beta Blockers

  • 5.

    Calcium Channel Blockers

  • 6.

    H2 blockers or H2 receptor agonists

  • 7.

    3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors

  • 8.

    Hypnotics

  • 9.

    Non-steroidal anti-inflammatory drugs (NSAIDS) [Including COX-II Inhibitors]

  • 10.

    Phenothiazine Antipsychotics

  • 11.

    Proton Pump Inhibitors (PPIs)

  • 12.

    Selective Serotonin Reuptake Inhibitors (SSRIs)

  • 13.

    Sucralfates

  • 14.

    Sulfonylurea Hypoglycemics

  • 15.

    Tricyclic Antidepressants

  • 16.

    Anticoagulants

Pairs of therapeutic classes
  • 1.

    Benzodiazepine + Hypnotic

  • 2.

    ACE Inhibitors + Angiotensin 2 Receptor Blockers

  • 3.

    H2 Blockers + Proton Pump Inhibitors